Caring Brands (CABR) Total Debt (2025)
Caring Brands' (CABR) quarterly Total Debt came in at $58650.0 in Q4 2025, down 55.32% quarter-over-quarter from $131268.0 in Q3 2025.
Caring Brands (CABR) Total Debt (2025) Analysis & Trends
Caring Brands' Total Debt history runs 1 years deep, the most recent figure standing at $58650.0 for Q4 2025.
- On a quarterly basis, Total Debt changed N/A year-over-year to $58650.0 in Q4 2025; TTM through Dec 2025 was $58650.0, a N/A change from a year earlier, with the FY2025 full-year figure at $58650.0, changed N/A from the prior year.
- Total Debt declined to $58650.0 in Q4 2025 per CABR's latest filing, from $131268.0 in the prior quarter.
- Across five years, Total Debt topped out at $131268.0 in Q3 2025 and bottomed at $58650.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Caring Brands | 20.08 Mn | 21.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 58,650.00 |
| Sep 30, 2025 | 131,268.00 |